Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| López de Mingo I et al. | 2025 | intact cell/cell culture, CT2A cells (mouse glioma cell line), N2A cells (murine neuroblastoma cell line) and C8-D1A (murine astrocyte type I cell line) | magnetic field, 50/60 Hz | - |
| Wang T et al. | 2025 | intact cell/cell culture, bone marrow-derived stromal cells (BMSCs) | magnetic field, 50/60 Hz | - |
| Goh J et al. | 2025 | intact cell/cell culture, human adenocarcinoma HeLa cells, human lung fibroblast IMR- 90 cells, human hepatocellular carcinoma Huh7 cells, human hepatocellular carcinoma Hep3B cells, B103 rat neuroblastoma cells, immortalized normal hepatic cell MIHA | magnetic field, 50/60 Hz | - |
| Tekam CKS et al. | 2025 | intact cell/cell culture, RFP (red fluorescent protein)-L929 mouse fibroblast cells, animal, rat/ Wistar | magnetic field, 50/60 Hz, signals/pulses | - |
| Betlej G et al. | 2024 | intact cell/cell culture, human retinal pigment epithelial cells (ARPE-19) and mouse retinal ganglion cells (RGC-5) | magnetic field, 50/60 Hz | - |
| Cai W et al. | 2024 | intact cell/cell culture | magnetic field, 50/60 Hz | - |
| Lu ZJ et al. | 2024 | intact cell/cell culture, bone marrow-derived mesenchymal stem cells (BM-MSCs) | magnetic field, signals/pulses, 50/60 Hz | - |
| Soydas T et al. | 2024 | intact cell/cell culture, NIH/3T3 aged mouse fibroblasts | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Sincak M et al. | 2024 | intact cell/cell culture, THP-1 cells (human monocytic leukemia cell line) and <i>Saccharomyces cerevisiae</i> CCY 21-4-13 | magnetic field, 50/60 Hz | - |
| Colciago A et al. | 2024 | intact cell/cell culture, Schwann cells (from sciatic nerves of neonatal rats) | magnetic field, 50/60 Hz | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
